MOST ACTIVE PINK SHEETS STOCKS

 

Here Is A List Of Most Active Pink Sheets Stocks


So here are a few names of most active pink sheets stocks that are currently in play. Current prices and volume are included in the text.

American Security Res. (ARSC) topped the most active pink sheets stock list today, but closed flat at 0.0001 on volume of a little more than 104 million shares.

Codima (CDMAD) This name was almost as active as ARSC, which is especially impressive because Codima has the dreaded “D” on the end of it’s symbol. CDMAD traded over 103 million shares and are at 0.0003, up 50% for the day. Today’s action could really draw in sub penny stock scalper types who are hoping for a pop before the weekend.

Tivus (TIVU) Remember this is TIVU not TIVO. However, are up 25%, trading at 0.0010 on volume of a little more than 70 million shares.

247mgi (TOFS) You have to admit that the name of the company is cool, but shares is flat at 0.0009 on volume of almost 68.5 million shares.

Quest Oil (QOIL) QOIL is very active once again and is trading at 0.0001 on volume of almost 63 million shares.

Radient Pharmaceutical (RXPC) Radient was once a huge winner for our subscribers at PSE, but the stock was trading on the AMEX back then and was at a higher price. Shares of RXPC are now at 0.0120 on volume of slightly more than 60 million shares. RXPC remains one of the most PR sensitive penny stock names in the microcap arena. Keep it on your list of stocks on a just in case basis.

Check back for more lists of some of the most active pink sheets stocks.

More Penny Stock News, IPO Updates and Stock Market Research.




 

 

Get MOST ACTIVE PINK SHEETS STOCKS Updates from our FREE eMail List

6:29 pm | | Tags: , , , , , , , , | No Comments »

RXPC

Radient Pharmaceuticals Corporation (RXPC) Jumps


rxpc RXPCShares of Radient Pharmaceuticals Corporation (Public, PINK:RXPC) closed 12.50% higher on Wednesday after the company said that it has released a corporate report which states the company’s business strategies.

Share holders of the RXPC have been seeing very tough time so far this year driven by host of bad news, which has taken the stock to $0.09 from $1.60 since the start of the this year.
RXPC was recently shifted its listing to bulletin boards on June 23, 2011 as the company messed up its balance sheet with full of debt and unpaid liability. The company was forced to list its lest on OTC as it couldn’t monetize its sole product , a colon cancer-monitoring test known as Onko-Sure.

RXPC Liability of 9 million


RXPC still has liability to creditors of about $9 million in its balance sheet. The company couldn’t pay the scheduled interest rate, which has pushed up its interest rate on its existing loans to 24%, including late penalties.

Despite,  RXPC’s attempt to convey its creditors to accept new equity shares in exchange of their loans, the company couldn’t be able to convince them.

In absence of any revenue, the only thing  RXPC could do it the issuing of new shares to its existing creditors, which could be around $9 million.

Shares of  RXPC are trading very near to its 52-week low of $0.07. We don’t find reason to buy this share, unless and until, markets get any clear strategy about the clearance of their debt.

More Penny Stock News, IPO Updates and Stock Market Research.


 


***Sign up above for FREE alerts on RXPC from our eMail list***

8:23 pm | | Tags: , | No Comments »